Literature DB >> 36267975

CT-based radiomics in predicting pathological response in non-small cell lung cancer patients receiving neoadjuvant immunotherapy.

Qian Lin1, Hai Jun Wu1, Qi Shi Song1, Yu Kai Tang1.   

Abstract

Objectives: In radiomics, high-throughput algorithms extract objective quantitative features from medical images. In this study, we evaluated CT-based radiomics features, clinical features, in-depth learning features, and a combination of features for predicting a good pathological response (GPR) in non-small cell lung cancer (NSCLC) patients receiving immunotherapy-based neoadjuvant therapy (NAT). Materials and methods: We reviewed 62 patients with NSCLC who received surgery after immunotherapy-based NAT and collected clinicopathological data and CT images before and after immunotherapy-based NAT. A series of image preprocessing was carried out on CT scanning images: tumor segmentation, conventional radiomics feature extraction, deep learning feature extraction, and normalization. Spearman correlation coefficient, principal component analysis (PCA), and least absolute shrinkage and selection operator (LASSO) were used to screen features. The pretreatment traditional radiomics combined with clinical characteristics (before_rad_cil) model and pretreatment deep learning characteristics (before_dl) model were constructed according to the data collected before treatment. The data collected after NAT created the after_rad_cil model and after_dl model. The entire model was jointly constructed by all clinical features, conventional radiomics features, and deep learning features before and after neoadjuvant treatment. Finally, according to the data obtained before and after treatment, the before_nomogram and after_nomogram were constructed.
Results: In the before_rad_cil model, four traditional radiomics features ("original_shape_flatness," "wavelet hhl_firer_skewness," "wavelet hlh_firer_skewness," and "wavelet lll_glcm_correlation") and two clinical features ("gender" and "N stage") were screened out to predict a GPR. The average prediction accuracy (ACC) after modeling with k-nearest neighbor (KNN) was 0.707. In the after_rad_cil model, nine features predictive of GPR were obtained after feature screening, among which seven were traditional radiomics features: "exponential_firer_skewness," "exponential_glrlm_runentropy," "log- sigma-5-0-mm-3d_firer_kurtosis," "logarithm_skewness," "original_shape_elongation," "original_shape_brilliance," and "wavelet llh_glcm_clustershade"; two were clinical features: "after_CRP" and "after lymphocyte percentage." The ACC after modeling with support vector machine (SVM) was 0.682. The before_dl model and after_dl model were modeled by SVM, and the ACC was 0.629 and 0.603, respectively. After feature screening, the entire model was constructed by multilayer perceptron (MLP), and the ACC of the GPR was the highest, 0.805. The calibration curve showed that the predictions of the GPR by the before_nomogram and after_nomogram were in consensus with the actual GPR.
Conclusion: CT-based radiomics has a good predictive ability for a GPR in NSCLC patients receiving immunotherapy-based NAT. Among the radiomics features combined with the clinicopathological information model, deep learning feature model, and the entire model, the entire model had the highest prediction accuracy.
Copyright © 2022 Lin, Wu, Song and Tang.

Entities:  

Keywords:  NSCLC; biomarkers; immunotherapy, neoadjuvant therapy; lung cancer; pathological response; radiomics

Year:  2022        PMID: 36267975      PMCID: PMC9577189          DOI: 10.3389/fonc.2022.937277

Source DB:  PubMed          Journal:  Front Oncol        ISSN: 2234-943X            Impact factor:   5.738


  53 in total

1.  MR-based radiomics signature in differentiating ocular adnexal lymphoma from idiopathic orbital inflammation.

Authors:  Jian Guo; Zhenyu Liu; Chen Shen; Zheng Li; Fei Yan; Jie Tian; Junfang Xian
Journal:  Eur Radiol       Date:  2018-04-09       Impact factor: 5.315

Review 2.  New Developments in Neoadjuvant Therapy for Lung Cancer.

Authors:  Paul A Bunn; Erin Schenk; Jose Pacheco; Anastasios Dimou
Journal:  Oncology (Williston Park)       Date:  2019-03-13       Impact factor: 2.990

3.  Tumor-Infiltrating Lymphocytes Improve Magee Equation-Based Prediction of Pathologic Complete Response in HR-Positive/HER2-Negative Breast Cancer.

Authors:  Fengling Li; Yuanyuan Zhao; Yani Wei; Yanfeng Xi; Hong Bu
Journal:  Am J Clin Pathol       Date:  2022-08-04       Impact factor: 5.400

4.  Development of a predictive radiomics model for lymph node metastases in pre-surgical CT-based stage IA non-small cell lung cancer.

Authors:  Mengdi Cong; Hui Feng; Jia-Liang Ren; Qian Xu; Lining Cong; Zhenzhou Hou; Yuan-Yuan Wang; Gaofeng Shi
Journal:  Lung Cancer       Date:  2019-11-09       Impact factor: 5.705

5.  Radiomic Detection of EGFR Mutations in NSCLC.

Authors:  Giovanni Rossi; Emanuele Barabino; Alessandro Fedeli; Gianluca Ficarra; Simona Coco; Alessandro Russo; Vincenzo Adamo; Francesco Buemi; Lodovica Zullo; Mariella Dono; Giuseppa De Luca; Luca Longo; Maria Giovanna Dal Bello; Marco Tagliamento; Angela Alama; Giuseppe Cittadini; Paolo Pronzato; Carlo Genova
Journal:  Cancer Res       Date:  2020-11-04       Impact factor: 12.701

6.  Construction and validation of a robust ferroptosis-associated gene signature predictive of prognosis in lung adenocarcinoma.

Authors:  Mi Zhou; Xin Zhu
Journal:  Medicine (Baltimore)       Date:  2022-04-22       Impact factor: 1.817

7.  Prognostic biomarker SGSM1 and its correlation with immune infiltration in gliomas.

Authors:  Junsheng Li; Jia Wang; Yaowei Ding; Jizong Zhao; Wen Wang
Journal:  BMC Cancer       Date:  2022-04-28       Impact factor: 4.638

8.  Breakthrough 5-year survival with pembrolizumab in Keynote-001 study: horizon shifting in advanced non-small cell lung cancer with immune check point inhibition.

Authors:  Madhawa de Silva; Malinda Itchins; Nick Pavlakis
Journal:  Ann Transl Med       Date:  2020-04

9.  Clinical, Conventional CT and Radiomic Feature-Based Machine Learning Models for Predicting ALK Rearrangement Status in Lung Adenocarcinoma Patients.

Authors:  Lan Song; Zhenchen Zhu; Li Mao; Xiuli Li; Wei Han; Huayang Du; Huanwen Wu; Wei Song; Zhengyu Jin
Journal:  Front Oncol       Date:  2020-03-20       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.